SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSTOB.L Regulatory News (STOB)

  • There is currently no data for STOB

Directorate Changes

21 May 2014 07:00

RNS Number : 6592H
Stobart Group Limited
21 May 2014
 

STOBART GROUP LIMITED

('Stobart' or 'the Group')

 

Directorate Changes

 

Stobart is pleased to announce the appointment of John Garbutt and John Coombs to its Board as non-executive directors and Richard Butcher as an executive director with effect from 1 July 2014. Paul Orchard-Lisle and Michael Kayser will be leaving the Board at the Group's AGM on 26 June 2014 after many years of valuable service to the Group.

 

Richard Butcher joined the Group in February 1997 and leads its Estates and Energy businesses. He will join the Board as an executive director with responsibility for the Group's Infrastructure, Energy and Rail Divisions. He also serves as Company Secretary and will be succeeded in that role, on his appointment to the Board, by Kate Willard who is deputy Company Secretary at present.

 

John Garbutt obtained a BSc Econ Honours degree from the LSE and began his career with Rowe & Pitman. He subsequently worked at ICI, Touche Remnant and Schroders and became a Director at Kleinwort Benson in 1987. Between 1991 and 2013 he worked at HSBC in a variety of senior roles, most recently as Director, Global Head of Corporate Governance in the investment businesses. John is a Justice of the Peace and an Alderman in the City of London and has had a wide range of charitable and civic appointments.

 

John Coombs is a Managing Director at Unilever Ventures where he has chaired the investment committee for the past 12 years. He has served as a non-executive director or non-executive chairman on the boards of 12 investee companies. John helped establish Unilever's ventures business in 2001, having joined Unilever in 1981 following his graduation in Engineering Science from Oxford University, and went on to hold a wide range of senior positions.

 

Paul Orchard-Lisle joined the Board in May 2011. He has chaired the Group's Property Board since joining the Group and we are pleased that he will continue in that role. Michael Kayser joined the Board in March 2008 and chairs the Audit Committee. The Board is grateful for the significant contributions that Paul and Michael have made to the Group.

 

Iain Ferguson commented: "I would like to thank Paul Orchard-Lisle and Michael Kayser, on the Group's behalf, for their service to the Board. I wish them well in the future and look forward to continuing to benefit from Paul's Chairmanship of our Property Board.

 

We welcome John Coombs and John Garbutt to the Group and look forward to working with Richard in his new role. Between them they bring significant commercial, financial and regulatory experience to the Board." 

No further information is required to be disclosed pursuant to Listing Rule 9.6.13.

 

 

ENQUIRIES

 

Stobart

+44 020 7851 9090

Andrew Tinkler, Chief Executive Officer

Ben Whawell, Chief Financial Officer

 

Lansons

Tony Langham (tonyl@lansons.com)

+44 20 7294 3617 / +44 7979 692287

Anna Schirmer (annas@lansons.com)

+44 20 7294 3605

 

Influence Associates

 

+44 20 7287 9610

Stuart Dyble/James Andrew

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAGUGDUSUDBGSB
Date   Source Headline
5th Jul 20192:33 pmRNSReceipt of merger control clearance
4th Jul 20192:14 pmRNSHolding(s) in Company
20th Jun 20199:30 amRNSNotice of Annual General Meeting
13th Jun 20191:06 pmRNSAnnual Report and Accounts
11th Jun 20191:27 pmRNSUpdate on Legal Proceedings
11th Jun 201910:05 amRNSTR-1: Notification of Major Interest in Shares
6th Jun 20197:00 amRNSDirector/PDMR Shareholding
5th Jun 20197:00 amRNSDirector/PDMR Shareholding
31st May 20197:00 amRNSDirector/PDMR Shareholding
29th May 20194:36 pmRNSDirector/PDMR Shareholding
29th May 20197:00 amRNSFinal Results
17th May 20191:41 pmRNSUpdate on Legal Proceedings
15th May 20197:00 amRNSBoard Changes
13th May 201911:15 amRNSFinal Results Publication
7th May 201910:00 amRNSHolding(s) in Company
7th May 201910:00 amRNSHolding(s) in Company
3rd May 20197:55 amRNSPricing of Exchangeable Bond
2nd May 20195:05 pmRNSExchangeable Bond Offering
1st Apr 20191:45 pmRNSBoard Appointment
13th Mar 20197:00 amRNSPre-Close Trading Statement
8th Mar 20194:36 pmRNSPrice Monitoring Extension
1st Mar 20192:01 pmRNSUpdate on High Court Judgment
1st Mar 20197:00 amRNSBoard Appointment
22nd Feb 20197:00 amRNSDisposal of Stobart Air and Propius
15th Feb 201910:10 amRNSHigh Court Judgment
24th Jan 201911:35 amRNSForm 8 (OPD) - Flybe Group PLC
22nd Jan 20197:00 amRNSTR-1: Notification of Major Interest in Shares
18th Jan 20194:35 pmRNSCorrection: Major Interest in Shares
18th Jan 20191:30 pmRNSAdmission of New Ordinary Shares
15th Jan 20197:00 amRNSTR-1: Notification of Major Interest in Shares
14th Jan 201912:00 pmRNSForm 8.5 (EPT/RI) - Flybe Group plc
11th Jan 20198:01 amRNSSubscription for Shares
11th Jan 20197:01 amRNSFormation of Aviation Joint Venture
11th Jan 20197:00 amRNSRecommended cash offer for Flybe Group
11th Dec 20188:46 amRNSUpdate on Q4 dividend
5th Dec 20184:00 pmRNSTR-1: Notification of Major Interest in Shares
3rd Dec 20187:00 amRNSUpdate on Capital Review and Q4 dividend
1st Nov 20187:00 amRNSStobart Air agreement with BA CityFlyer
25th Oct 201812:02 pmRNSPrice Monitoring Extension
24th Oct 20187:00 amRNSInterim Results
2nd Oct 20185:00 pmRNSTR-1: Notification of Major Interest in Shares
20th Sep 20187:00 amRNSPre-Close Trading Statement
6th Sep 20187:00 amRNSQuarterly Dividend
23rd Aug 20187:00 amRNSBoard Appointments
8th Aug 20187:00 amRNSNotice of Results
25th Jul 20189:24 amRNSAppointment of Advisers
11th Jul 201810:14 amRNSEGM Update
9th Jul 20185:47 pmRNSBoard plans and actions following AGM
9th Jul 20187:00 amRNSResult of AGM and change of director
6th Jul 20184:24 pmRNSResults of the Annual General Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.